Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.5.1.2 (
DNA ligase
)
2,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calpain activity is thought to be essential for the execution of apoptotic cell death in certain experimental models. In the present study, the physiological inhibitor of calpain,
calpastatin
, was found to be cleaved in three different apoptotic systems. The 110-120 kDa
calpastatin
protein of Jurkat T-lymphocytes and U937 monocytic leukemia cells was cleaved to a 65-70 kDa form after the induction of apoptosis with anti-CD95 monoclonal antibody, staurosporine or TNF. Cleavage of
calpastatin
in apoptotic cells occurred simultaneously with the cleavage of the
DNA repair enzyme
, poly(ADP-ribose) polymerase. The caspase inhibitors VAD-cmk and IETD-fmk prevented
calpastatin
cleavage in all three systems. Calpain inhibitor I, however, suppressed
calpastatin
cleavage only during TNF-induced apoptosis. Other protease inhibitors, such as lactacystin and pepstatin A, did not confer any significant protection against apoptotic
calpastatin
cleavage. The results from in vitro incubations with cell lysates and purified enzymes showed that calpain I, calpain II and recombinant caspase-3, all cleaved
calpastatin
, with varying efficiency. In conclusion, the results of the present study suggest that caspases may cleave
calpastatin
and thus, regulate calpain activity during apoptotic cell death.
...
PMID:Cleavage of the calpain inhibitor, calpastatin, during apoptosis. 989 9